30.01.2025 • News
AstraZeneca Plans $570 Million Investment in Canada
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.
investment
27.01.2025 • News
Amgen Opens New Drug Substance Facility in the US
At the end of last week, US biotech Amgen officially opened its newest drug substance facility in Holly Springs, North Carolina, US. The opening day also saw the groundbreaking of a further $1 billion expansion at the North Carolina site, announced less than two months ago.
13.01.2025 • News
AkzoNobel Invests €22 Million Streamlining France Operations
AkzoNobel has proposed a €22 million investment to make its Montataire site a flagship for decorative paint production in France.
30.12.2024 • News
Carbios Postpones Construction of PET Bio-Recycling Facility in France
French green chemistry company Carbios announced that it is postponing the construction of its PET bio-recycling plant in Longlaville for six to nine months due to delayed funding pending completion of additional financing under satisfactory conditions. The company aims to complete the financing as soon as possible to meet market needs from 2027. Carbios expects to sign several binding commercial contracts in the first half of 2025.
27.12.2024 • News
Messer Starts Operation of New Green CO2 Plant in Czechia
German family-owned industrial gases producer Messer has started operations at a new plant for the production of green carbon dioxide (CO2) at its Vrdy site in the Czech Republic.
18.12.2024 • News
Toray to Build Pilot Facility for All-Carbon CO2 Separation Membrane in Japan
Japan’s Toray Industries plans to install a pilot facility for its all-carbon carbon dioxide (CO2) separation membrane at its plant in Shiga, Japan.
16.12.2024 • News
Clariant Starts New Additives Line in China
Clariant is expanding its Cangzhou production site to manufacture the multifunctional additive Nylostab S-EED.
16.12.2024 • News
Novo Nordisk to Build New Production Facility in Odense, Denmark
Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.
12.12.2024 • News
Greensand CCS Project Partners Take Final Investment Decision
Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage operations in a depleted oil field in the Danish North Sea set to begin at the end of 2025/early 2026.
11.12.2024 • News • Bioprocessing
Amgen Plans $1 Billion Manufacturing Expansion in North Carolina
In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at its US site in Holy Springs, North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.
06.12.2024 • News
Lilly Plans $3 Billion Expansion of US Facility in Wisconsin
US drug manufacturer Eli Lilly announced a $3 billion expansion of its US manufacturing facility in Kenosha County, Wisconsin, that the company acquired earlier this year. This investment will extend the company's global parenteral (injectable) product manufacturing network for diabetes, obesity and future medicines across therapeutic areas.
04.12.2024 • News
Sanofi to Invest $1 Billion in New Insulin Manufacturing Site in China
Sanofi plans to invest around €1 billion ($1.1 billion) in the construction of a new insulin production facility in Beijing – the company's largest single investment in China to date. This was reported by Reuters and other news agencies.
03.12.2024 • News
Givaudan Hikes Encapsulation Technologies Capacity in Mexico
In a move to increase its competitive advantage in Latin America, Swiss flavors, fragrances and active cosmetic ingredients manufacturer Givaudan has inaugurated its newly expanded production facility at the Pedro Escobedo site in Mexico, enhancing the company’s encapsulation technologies.
03.12.2024 • News
Air Liquide to Launch New Renewable Hydrogen Production Facility in France
French industrial gases group Air Liquide is launching a renewable hydrogen production project at La Mède, France, to supply TotalEnergies’ biorefinery at that site under a long-term contract. AirLiquide will build, own, and operate the new unit with a capacity of 25,000 t/y, producing hydrogen from recycled biogenic by-products instead of fossil hydrocarbons.
02.12.2024 • News
Ube to Increase Capacity for High-Purity Nitric Acid in Japan
Japanese chemical group Ube wants to increase production capacity for high-purity nitric acid at its chemical plant in Ube City, Yamaguchi Prefecture.
02.12.2024 • News
Hovione Expands Spray Drying Capacities in the USA and Ireland
Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.
29.11.2024 • News
ADNOC Launches $80 Billion Investment Vehicle XRG
Abu Dhabi National Oil Company (ADNOC) has launched XRG, an international lower-carbon energy and chemicals investment company, with an enterprise value of over $80 billion.
29.11.2024 • News • Bioprocessing
Samsung Biologics Signs Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.
26.11.2024 • News
IMCD Expands Pharmaceuticals Technical Centre and Wins Laura Marshall Award
IMCD Group, a global distribution partner and formulator of specialty chemicals and ingredients, recently announced the expansion of its Pharmaceuticals Technical Centre in Jakarta, Indonesia. This facility will serve as the hub for pharmaceutical development and innovation across Southeast Asia, Australia, and New Zealand.
21.11.2024 • News
Avantor Opens New US Innovation Center in Bridgewater
Avantor has opened its latest Innovation Center in Bridgewater, New Jersey, US, “to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows.” The new center is now part of the company’s network of 13 global research and innovation centers.
20.11.2024 • News
Siegfried Opens New Drug Substances R&D Center in Evionnaz
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow chemistry, advanced distillation and process analytical technology, as well as new office space.
15.11.2024 • News • Bioprocessing
Ambiopharm Breaks Ground on $28 Million Expansion
Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2) capacity expansion project at its Shanghai manufacturing site. This $28 million (€26.6 million) project reflects the company’s commitment to serving growing global demand and confidence in China’s vital role in the global pharmaceutical supply chain.
14.11.2024 • News
AstraZeneca to Invest $3.5 Billion in the US
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
12.11.2024 • News
Nouryon Completes Expansion for Organic Peroxides in China
Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion doubled production capacity to 6,000 tons of organic peroxide products each, which are sold under the Perkadox 14 and Trigonox 101 brands.
12.11.2024 • News • Bioprocessing
Lonza to Expand Bioconjugation in Visp, Switzerland
Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest in additional bioconjugation capabilities in Visp, Switzerland.
11.11.2024 • News
Evonik to Expand Specialty Amine Production in Nanjing, China
German specialty chemicals group Evonik broke ground on its plant expansion for specialty amines at its site Nanjing, China, on Nov. 8. Construction work is expected to be completed in 2026.
08.11.2024 • News
SABIC Opens Multi-Million-Dollar Resin Manufacturing Facility in Singapore
SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced specialty chemical manufacturing facility in the region producing the high-performance thermoplastic, ultem resin.
05.11.2024 • News
Ardena Expands European Bioanalytical Capabilities
Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.
31.10.2024 • News • Bioprocessing
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), today announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million (€11.9 million) investment to increase GMP bioconjugation capacity.
29.10.2024 • News
GSK to Invest $800 Million in US Manufacturing Facility
British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.
25.10.2024 • News
Eni to Invest €2 Billion in the Transformation and Relaunch of Versalis
Italian energy group Eni has finalized its transformation and relaunch plan for Versalis, its chemicals business. As part of the plan, Eni will invest about €2 billion to reduce emissions by approximately 1 million t of CO2, currently about 40% of Versalis' emissions in Italy.
25.10.2024 • News
Rentschler Plans New Buffer Media Facility at its Headquarters
In a move to further increase production efficiency and modernize the site, German contract development and manufacturing organization (CDMO) Rentschler Biopharma plans to construct a new buffer media station at its company headquarters in Laupheim. According to Rentschler, this is the largest single investment in the German site.
23.10.2024 • News
Avantium Opens Biobased FDCA Plant in the Netherlands
Dutch renewables specialist Avantium has officially opened its FDCA (furandicarboxylic acid) flagship plant in Delfzijl, the Netherlands. Plans for what was said to be the world's first commercial-scale production plant for FDCA were first announced in December 2021.
17.10.2024 • News
Cambrex Opens New Stability Storage Facility
Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.
04.10.2024 • News
Piramal to Expand US Facility for Sterile Injectables
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
ICIG
Samsung Biologics
Sanner GmbH
WeylChem International GmbH
European Chemical Industry Council - Cefic aisbl
Nouryon
Covestro
Aragen Life Sciences Ltd.
Bachem
Archroma
Sanofi S.A.
Boehringer Ingelheim
IMCD Group B.V.
DuPont Company
Ferrostaal
Cambrex Corporation
A.T. Kearney GmbH
Gelest, Inc.
Perstorp Holding AB
Eli Lilly and Company
Serán Bioscience, LLC
International Flavors & Fragrances Inc. (IFF)
Syensqo
Toray Industries, Inc.
Flamma Group
Fujifilm
Arkema
Solvias AG
Capchem Technology USA Inc.
Evonik Industries AG
AmbioPharm, Inc.
Dow Chemical Company
OMV Aktiengesellschaft
Mitsubishi Chemical Europe GmbH
Brenntag SE
Vynova Group
Pace Life Sciences
LANXESS Deutschland GmbH
Axplora
ISPE D/A/CH e.V.
Biontech
Integrals Power
Navin Molecular
Orion S.A.
Trinseo LLC
AbbVie Dt. GmbH & Co.KG
SchüllerConsulting
OCI Global
De Paauw Sustainable Resources (DPSR)
Aenova Holding GmbH